Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00972101 Background | Sep 2009 → Sep 2011 | disease related to hematopoietic stem cell transplant, leukemia, lymphoma | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00972101 ↗ |
| Route | Subcutaneous | “This drug is given through a needle under the skin 1-2 times a day for 3-7 days” NCT00972101 ↗ |